MedPath

Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming

Not Applicable
Conditions
Acute Respiratory Failure
Interventions
Other: Priming of ECMO circuit with 0.9% NaCl
Other: Priming of ECMO circuit with Balanced Solution
Other: Priming of ECMO circuit with Ringer Lactate
Registration Number
NCT02609360
Lead Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Brief Summary

Crystalloid solutions modify acid-base equilibrium according to their electrolyte composition. Moreover, it has been suggested that these alterations are generated by the difference between the solution strong ion difference (SID) and the plasma bicarbonate level. An increased risk of acute kidney injury and renal replacement therapy has been associated to the infusion of chloride rich crystalloids. This study aims to compare, in patients with acute respiratory failure undergoing ECMO support, the effects on acid-base status and renal function of crystalloids commonly employed for circuit priming to a balanced solution created with a SID equal to patients' bicarbonate level.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Patients with Acute Respiratory Failure in need for ECMO treatment
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
0.9% NaClPriming of ECMO circuit with 0.9% NaClCircuit priming will be performed with 0.9% NaCl solution
Balanced SolutionPriming of ECMO circuit with Balanced SolutionCircuit priming will be performed with a Balanced Solution created by mixing 0.9% NaCl, Sodium bicarbonate (8.4%) and injectable sterile water, in order to obtain a solution with constant sodium concentration (140 mEq/l) and SID equal to patient's bicarbonate level.
Ringer LactatePriming of ECMO circuit with Ringer LactateCircuit priming will be performed with Ringer Lactated
Primary Outcome Measures
NameTimeMethod
Variation in Acid-Base Equilibrium (Base Excess)First 24 hours after ECMO start
Secondary Outcome Measures
NameTimeMethod
Variation in Renal FunctionFirst 24 hours after ECMO start
Variation in Acid-Base Equilibrium (pH)First 24 hours after ECMO start

Trial Locations

Locations (1)

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath